A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. Nyang'wa BT, Berry C, Kazounis E, Motta I, et al. N Engl J Med 2022;387:2331-2343.

Read + Share

Amedeo Smart

Independent Medical Education

Nyang'wa BT, Berry C, Kazounis E, Motta I, et al. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med 2022;387:2331-2343.
PMID: 36546625